News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
168 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (3049)
February (3199)
March (3214)
April (3461)
May (3810)
June (3552)
July (3330)
August (2848)
September (3192)
October (3888)
November (3400)
December (2467)
Day
1 (158)
2 (163)
3 (102)
6 (153)
7 (152)
8 (152)
9 (194)
10 (107)
13 (153)
14 (175)
15 (179)
16 (162)
17 (120)
18 (1)
20 (146)
21 (192)
22 (191)
23 (193)
24 (168)
27 (205)
28 (277)
29 (183)
30 (208)
31 (154)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
6
7
8
9
10
13
14
15
16
17
18
20
21
22
23
24
27
28
29
30
31
Drug Development
Schering-Plough Corporation’s Asenapine Meets Primary Endpoint in Long-Term Schizophrenia Relapse Prevention Trial
October 24, 2008
·
2 min read
Business
Nektar Therapeutics to Announce Financial Results for the Third Quarter of 2008 on Thursday, November 6, 2008 After Close of U.S.-Based Financial Markets
October 24, 2008
·
1 min read
Deals
Pacgen Biopharmaceuticals Corporation Enters Into a Letter of Intent With Medigen Biotechnology Corporation
October 24, 2008
·
9 min read
Business
Leading Heart Specialist Joins Duska Therapeutics, Inc. as Scientific Consultant
October 24, 2008
·
6 min read
BioCapital
PharmAthene, Inc. to Present at the 7th Annual Biotechnology Industry Organization (BIO) Investor Forum in San Francisco
October 24, 2008
·
1 min read
Drug Development
Vaxart, Inc. Demonstrates Efficacy of Oral Avian Flu Vaccine in Preclinical Studies
October 24, 2008
·
5 min read
Biotech Bay
Monogram Biosciences Announces Conference Call
October 24, 2008
·
2 min read
Pharm Country
Integra LifeSciences Holdings Corporation Featured in Forbes 2008 List of 200 Best Small Companies
October 24, 2008
·
1 min read
Drug Development
Infinity Pharmaceuticals, Inc.'s Hedgehog Pathway Inhibitor IPI-926 Demonstrates Significant Tumor Growth Inhibition in Human Pancreatic Cancer Model
October 24, 2008
·
1 min read
Drug Development
Ardea Biosciences, Inc. to Present Clinical Data on its Lead MEK Inhibitor, RDEA119, at the ASCO–NCI–EORTC 2nd Annual Meeting on Molecular Markers in Cancer
October 24, 2008
·
1 min read
Previous
5 of 17
Next